Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.02 USD
Change Today +0.0003 / 1.89%
Volume 1.3M
EAPH On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

easton pharmaceuticals inc (EAPH) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
03/31/14 - $0.06
52 Week Low
12/22/14 - $0.0060
Market Cap
1.9M
Average Volume 10 Days
3.5M
EPS TTM
--
Shares Outstanding
115.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EASTON PHARMACEUTICALS INC (EAPH)

Related News

No related news articles were found.

easton pharmaceuticals inc (EAPH) Related Businessweek News

No Related Businessweek News Found

easton pharmaceuticals inc (EAPH) Details

Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug. The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.

easton pharmaceuticals inc (EAPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

easton pharmaceuticals inc (EAPH) Key Developments

Easton Pharmaceuticals Inc. Executes a Distribution and Intellectual Property Agreement with NutraShop Global Stores, Inc

Easton Pharmaceuticals Inc. announced that it has executed a distribution and intellectual property agreement for its full range of OTC therapeutic and specialty products with NutraShop Global Stores, Inc. currently serving thousands of trusting online customers looking for Quality Life Wellness Products.

Easton Pharmaceuticals Inc. Engages Kapadia Chartered Accountants Professional Corporation as Auditor

Easton Pharmaceuticals Inc. announced that it is engaging independent auditor Kapadia Chartered Accountants Professional Corporation. The company has provided a retainer and has formally engaged accredited Auditor Kapadia Chartered Accountants PC to perform an independent audit on the company's financial statements for the years ending 2013 and 2014 utilizing IFRS International Auditing Standard.

Easton Pharmaceuticals Provides AMFIL Update on the mPact - GROzone Antimicrobial System

Easton Pharmaceuticals Inc. announced update on the mPact - GROzone Antimicrobial System through its investment and ownership interest in AMFIL Technologies. Easton's partner AMFIL Technologies has updated the company and advised that the mPact - GROzone Antimicrobial Systems has received broad interest, is in discussions and has signed non disclosure agreements with the hopes to soon integrate other mPact - GROzone Antimicrobial Systems into a licensed large Canadian medical marijuana grow facility in Canada and into possibly another very large facility who has received a letter to build from Health Canada under the new MMPR system.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EAPH:US $0.02 USD +0.0003

EAPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EAPH.
View Industry Companies
 

Industry Analysis

EAPH

Industry Average

Valuation EAPH Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EASTON PHARMACEUTICALS INC, please visit www.eastonpharmaceuticalsinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.